EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort

Kelly N H Nudelman, Trever Jackson, Malia Rumbaugh, Ani Eloyan, Marco Abreu, Jeffrey L Dage, Casey Snoddy, Kelley M Faber, Tatiana Foroud, Dustin B Hammers, DIAN/DIAN-TU Clinical/Genetics Committee, Alexander Taurone und 31 weitere

Alzheimer's & Dementia · 2023-11 · 19 (S9)

DOI: 10.1002/alz.13482 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.10.2023. Verfasst von Kelly N H Nudelman und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

One goal of the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) is to investigate the genetic etiology of early onset (40–64 years) cognitive impairment. Toward this goal, LEADS participants are screened for known pathogenic variants.

Methods

LEADS amyloid‐positive early‐onset Alzheimer's disease (EOAD) or negative early‐onset non‐AD (EOnonAD) cases were whole exome sequenced ( N = 299). Pathogenic variant frequency in APP, PSEN1, PSEN2, GRN, MAPT , and C9ORF72 was assessed for EOAD and EOnonAD. Gene burden testing was performed in cases compared to similar‐age cognitively normal controls in the Parkinson's Progression Markers Initiative (PPMI) study.

Results

Previously reported pathogenic variants in the six genes were identified in 1.35% of EOAD (3/223) and 6.58% of EOnonAD (5/76). No genes showed enrichment for carriers of rare functional variants in LEADS cases.

Discussion

Results suggest that LEADS is enriched for novel genetic causative variants, as previously reported variants are not observed in most cases. Highlights Sequencing identified eight cognitively impaired pathogenic variant carriers. Pathogenic variants were identified in PSEN1 , GRN , MAPT , and C9ORF72 . Rare variants were not enriched in APP, PSEN1/2, GRN , and MAPT . The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) is a key resource for early‐onset Alzheimer's genetic research

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmyloid beta-Protein PrecursorC9orf72 ProteinGenetic TestingLongitudinal StudiesMutationPresenilin-1Presenilin-2

Stichwörter der Autor:innen

APPAlzheimer's diseaseC9ORF7GRNMAPTPSEN1PSEN2dementiaearly onsetgeneticssequencing

Substanzen

Amyloid beta-Protein PrecursorC9orf72 ProteinPresenilin-1Presenilin-2

Autor:innen und Institutionen

  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Indiana Alzheimer's Disease Research Center, Indianapolis, Indiana, USA.
  • Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA.
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Washington University School of Medicine, St. Louis, Missouri, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Förderung

  • NIH HHS
  • NIA NIH HHS
  • Alzheimer's Association
  • National Institutes of Health
  • Michael J. Fox Foundation for Parkinson's Research

Zitieren

APA

Nudelman, K. N. H., Jackson, T., Rumbaugh, M., Eloyan, A., Abreu, M., Dage, J. L., Snoddy, C., Faber, K. M., Foroud, T., Hammers, D. B., DIAN/DIAN-TU Clinical/Genetics Committee, Taurone, A., Thangarajah, M., Aisen, P., Beckett, L., Kramer, J., Koeppe, R., Kukull, W. A., Murray, M. E., …, & LEADS Consortium (2023). Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort. Alzheimer's & Dementia, 19(S9). https://doi.org/10.1002/alz.13482

Vancouver

Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, et al. Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort. Alzheimer's & Dementia. 2023;19(S9). doi:10.1002/alz.13482

BibTeX
@article{Nudelman2023,
  author = {Nudelman, Kelly N H and Jackson, Trever and Rumbaugh, Malia and Eloyan, Ani and Abreu, Marco and Dage, Jeffrey L and Snoddy, Casey and Faber, Kelley M and Foroud, Tatiana and Hammers, Dustin B and DIAN/DIAN-TU Clinical/Genetics Committee, DIAN/DIAN-TU Clinical/Genetics Committee and Taurone, Alexander and Thangarajah, Maryanne and Aisen, Paul and Beckett, Laurel and Kramer, Joel and Koeppe, Robert and Kukull, Walter A and Murray, Melissa E and Toga, Arthur W and Vemuri, Prashanthi and Atri, Alireza and Day, Gregory S and Duara, Ranjan and Graff-Radford, Neill R and Honig, Lawrence S and Jones, David T and Masdeu, Joseph C and Mendez, Mario and Musiek, Erik and Onyike, Chiadi U and Riddle, Meghan and Rogalski, Emily and Salloway, Stephen and Sha, Sharon J and Turner, R Scott and Wingo, Thomas S and Wolk, David A and Carrillo, Maria C and Dickerson, Bradford C and Rabinovici, Gil D and Apostolova, Liana G and LEADS Consortium, LEADS Consortium},
  title = {Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {S9},
  doi = {10.1002/alz.13482}
}
Kostenlos starten →